ACP: Recommendations Developed for Newer Type 2 Diabetes Medications
Strong recommendation given for addition of SGLT-2 or GLP-1 agonist to metformin and lifestyle modifications
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.